ESCRS Homepage

March 2003
IN THIS ISSUE

New ESCRS trial in bid to cut endophthalmitis rate to 0.01%


Lasik corrects refractive errors after PK in selected patients

Africa-Luz mobilises to provide eye care in regions riven by poverty

Multifocal IOL
choice hinges on patterns of daily routine

Anti-histamine drug mitigates risk of developing DLK after Lasik, says study

Untreated eyelid inflammatory disorders pose risk for postoperative complications

Thermotopography shows ‘enormous promise’
for diagnosis and treatment of eye diseases

Lasik offers ‘very effective treatment’ for
refractive errors after PK, says US specialist

Good results with PRK and Lasek rival Lasik for top spot in refractive excimer laser surgery

Orbital lymphomas respond well to local, systemic therapies, says study

Laser technologies still beam but economy and consumer demand will determine future of refractive surgery

Legally blind cardiologist finds new beat in low vision rehabilitation

‘Pivotal’ anti-TGF antibody therapy reduces
filtering bleb wound formation, says report

Neuroprotective agents stem optic nerve damage
by ‘offering a solution’ to open-angle glaucoma

Echothiophate iodide shortage leaves US specialists struggling to find alternative for acute cases

Postoperative complications of PK will have serious consequences unless tackled 'aggressively’

Private refractive clinics claim young specialists as public waiting lists grow in Canadian eye surgery

German doctors’ helpers oil the cogs of the private ophthalmic practice

Study of 900 ICLs reveals good safety and long-term refractive results, says Spanish specialist

New toric IOL corrects high corneal astigmatism after cataract surgery, Austrian study reveals

IVF children run increased risk of developing
retinoblastoma, claim Dutch researchers

Suture-free DLEK preserves corneal surface topography and ensures faster wound healing

The day I said goodbye to cataracts and hello to the world without glasses

Retina specialists and trauma ophthalmologists
prepare to trade notes at joint Hungarian conference

Night blindness casts bogeyman into the shadows

Erbium laser phaco requires longer time but less energy for moderately hard cataracts

FEATURES
From The Editor
Reflections on Refractive Surgery
In Your Good Books
Bio-ophthalmology
In The Driving Seat
Prime Site
The Collector's Eye
Regulatory Matters



Study of 900 ICLs reveals good safety and long-term refractive results, says Spanish specialist

Ana Hidalgo-Simón MD, PhD
in Barcelona

Javier Puig MD

Implantable contact lenses (ICLs, Staar) are safe and afford good long-term refractive results, according to a study of 900 cases carried out by Spanish ophthalmologist Javier Puig MD.

A total of 901 eyes of 547 patients were included in the retrospective study. The myopic power of the lens implanted ranged from -3.0 D to -22.5 D. The spherical equivalent (SE) range operated on was – 8.0 D to –29.9 D.

The implants were performed between February 1997 and June 2001 and follow-up periods ranged from six to 54 months. Of the 900 eyes, 282 were bioptics. The mean SE of the whole series improved from -16.98 D preoperatively to -1.19 D one week after implanting the ICL. That level was maintained at three months, six months and one year.

Mean uncorrected visual acuity improved from 0.02 preoperatively to 0.62 after implantation (0.025 for bioptics). After the application of Lasik surgery three months after implantation, visual acuity improved in the bioptic group to 0.69. The improvement persisted at six and 12 months.
Best corrected visual acuity improved an average of 1.27 Snellen lines in the general group and 2.03 lines in the bioptics group.
The most frequent intraoperative complication recorded was corneal oedema, observed in 2.99% of cases. Other complications were relatively rare and included iridectomy bleeding (0.99%); Descement’s membrane detachment (0.44%); discoria (0.33%); and inverted ICL (0.11%).

Early postoperative complications included incisional oedema in 13.87% of cases. Superficial punctate keratitis (SPK) and insufficient vaulting were seen in 8.87% and 4.66% of implants. Not all cases of insufficient vaulting resulted in cataracts, but some vaulting was observed in most cataract cases.
“The main reason for this to happen is that there is a slight margin for error in the calculation of the final position of the lens in the sulcus,” he explained.
Less common complications at this stage included pupillary block (1.99%), corneal oedema (1.88%) and the presence of pigment in the endothelium (0.99%).

The main late postoperative complication was the presence of halos and glare (38%). Pigment deposition on the lens (35%) and rises in IOP (30%) were also relatively frequent. Other late complications such as deposits of pigment on the endothelium and decentration were observed in between 2% and 4% of the implants. Monocular diplopia, retinal detachment and macular haemorrhage were seen in less than 1%.

Cataracts developed in a small proportion of patients (2.5%). They appeared between a few months and up to a year postoperatively. Most of theses case were V2 type lenses.
Newer models implanted more recently (V3 and V4) have a clearly reduced incidence of cataracts, but Dr Puig acknowledged that these cases also have a shorter follow-up period of observation.Four lenses required explantation, all due to different causes: excessive glare and halos at night; a haptic fold that resulted in irritative inflammation; an excessive vault which resulted in unresponsive midriasis; and surprise refractive results that could not be corrected with Lasik. The explantation process is extremely simple with these lenses, he noted.

Dr Puig considered the predictability of the lenses good, with 76% of patients ending up within 1.0 D of target refraction. Stability one year after surgery was 97%.

Javier Puig MD
Barcelona Institute of Ophthalmology, Spain
Email: 29213jpg@comb.es

 

Top